Naslov
Current treatment options for people with Alzheimer's disease in Croatia

Autori
Mimica, Ninoslav ; Presečki, Paola

Izvornik
Chemico-biological interactions (0009-2797) 187 (2010), 1/3; 409-410

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Alzheimer's disease; Antidementia drugs; Cholinesterase inhibitors; Croatia; Dementia

Sažetak
About 16% of the population in Croatia is older than 65 years. Croatia has no register of persons with dementia (PWD), but based on a calculation that 10% of persons over 65 years are affected by dementia, the approximate number of PWD would be 80, 000, the majority being patients with Alzheimer's disease (AD). Psychogeriatric departments exist in hospitals, but there are almost no nursing homes and an insufficient number of daily care centres for PWD. Antidementia drugs registered in Croatia are donepezil, rivastigmine and memantine. Clinical studies of new antidementia drugs have been conducted in Croatia since 1989. At present, studies of several antidementia drugs are underway at different testing stages.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

Napomena
S.I. ; Rad je prezentiran na skupu 10th International Meeting on Cholinesterases ; Elsa Reiner, Jean Massoulie, Terrone Rosenbarry, Peter Eyer, Gabi Armitai, Zoran Radić, Zrinka Kovarik (ur.).

POVEZANOST RADA